Is Takeda Pharmaceutical Company Limited overvalued?

Takeda Pharmaceutical Company Limited (TAK) looks undervalued — trading about 122% below its fair value.

Undervalued

Price

$16.77

Fair value

$37.25

Current P/E

9.8

Normal P/E

21.7

Market cap

$52.99B

Dividend yield

3.5%

Return on equity

2.5%

Sector

Healthcare

Fair value compares TAK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 4 Jul 2026.

Related stocks